TSBX
Turnstone Biologics
TSBX
TSBX
Delisted
TSBX was delisted on the 8th of August, 2025.
24 hedge funds and large institutions have $6.37M invested in Turnstone Biologics in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
81% less capital invested
Capital invested by funds: $33.3M → $6.37M (-$26.9M)
96% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 24
Holders
24
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$33.9K | |
| 2 | +$21K | |
| 3 | +$19K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.07K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.55K |
Top Sellers
| 1 | -$1.2M | |
| 2 | -$566K | |
| 3 | -$192K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$134K |
| 5 |
KSWA
Kathleen S. Wright Associates
Pittsburgh,
Pennsylvania
|
-$111K |